Does Rallies show TMHC 10-K and 10-Q filings?

Rallies organizes TMHC SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.

Is TMHC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TMHC. It does not provide personalized investment advice.

TMHC (Taylor Morrison Home Corporation Common Stock) Stock Analysis - SEC Filings

Taylor Morrison Home Corporation Common Stock (TMHC) is a publicly traded Consumer Cyclical sector company. As of May 21, 2026, TMHC trades at $57.69 with a market cap of $5.23B and a P/E ratio of 7.26. TMHC moved +0.00% today. Year to date, TMHC is -2.51%; over the trailing twelve months it is -2.26%. Its 52-week range spans $51.90 to $75.49. Analyst consensus is buy with an average price target of $64.50. Rallies surfaces TMHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find TMHC SEC filings?

Rallies organizes TMHC SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

TMHC Key Metrics

Key financial metrics for TMHC
Metric	Value
Price	$57.69
Market Cap	$5.23B
P/E Ratio	7.26
EPS	$7.90
Dividend Yield	0.00%
52-Week High	$75.49
52-Week Low	$51.90
Volume	6.77K
Avg Volume	0
Revenue (TTM)	$8.12B
Net Income	$791.26M
Gross Margin	23.03%

Latest TMHC News

Taylor Morrison jumps 4% as rate-cut hopes lift homebuilders, buyback story supports — May 6, 2026
Taylor Morrison slides as Treasury yields jump, rekindling mortgage-rate pressure on homebuilders — May 4, 2026
TMHC slides as mortgage applications fall and rates tick higher, pressuring homebuilders — Apr 29, 2026
Taylor Morrison Posts $1.3B Q1 Revenue and 23% Backlog Growth — Apr 23, 2026
Taylor Morrison jumps after Q1 EPS beat, guidance reaffirmed, buybacks highlighted — Apr 22, 2026

Recent TMHC Insider Trades

Warren Denise sold 2.98K (~$205.87K) on Feb 13, 2026.
Warren Denise sold 100 (~$6.93K) on Feb 13, 2026.
Merrill Stevin Todd sold 4.41K (~$309.02K) on Sep 12, 2025.

TMHC Analyst Consensus

7 analysts cover TMHC: 0 strong buy, 5 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $64.50.

Common questions about TMHC

Where can I find TMHC SEC filings?: Rallies organizes TMHC SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show TMHC 10-K and 10-Q filings?: Rallies organizes TMHC SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is TMHC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TMHC. It does not provide personalized investment advice.